These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34942340)

  • 41. Defining the 90-day cost structure of lower extremity revascularization for alternative payment model assessment.
    Duwayri YM; Aiello FA; Tracci MC; Nedza S; Ryan PC; Adams JG; Shutze WP; Lum YW; Woo K
    J Vasc Surg; 2021 Feb; 73(2):662-673.e3. PubMed ID: 32652115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of revascularization methods for peripheral arterial disease in diabetics: Changing trends in lower extremity revascularization from 2008 to 2014.
    Qiu Q; Stefanopoulos S; Kaissieh D; Wandtke M; Ren G; Osman M; Nazzal M; Ahmed A
    Vascular; 2022 Apr; 30(2):246-254. PubMed ID: 33947287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fewer Complications in the Obese Following Lower Extremity Endovascular Interventions.
    Shean KE; Zettervall SL; Deery SE; O'Donnell TFX; Soden PA; Johnson JM; Guzman RJ; Schermerhorn ML
    Ann Vasc Surg; 2018 May; 49():17-23. PubMed ID: 29421418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lower Extremity Revascularization for Chronic Limb-Threatening Ischemia among Patients at the Extremes of Age.
    Kim TI; Aboian E; Fischer U; Zhang Y; Guzman RJ; Ochoa Chaar CI
    Ann Vasc Surg; 2021 Apr; 72():517-528. PubMed ID: 32927042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Outcomes and Cost of Endovascular Management Versus Surgical Bypass for the Management of Lower Extremities Peripheral Arterial Disease.
    Doshi R; Changal KH; Gupta R; Shah J; Patel K; Desai R; Meraj P; Syed MA; Sheikh AM
    Am J Cardiol; 2018 Nov; 122(10):1790-1796. PubMed ID: 30217372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
    Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of preoperative testing for blood glucose concentration and haemoglobin A1c on mortality, changes in management and complications in noncardiac elective surgery: a systematic review.
    Bock M; Johansson T; Fritsch G; Flamm M; Hansbauer B; Mann E; Sönnichsen A
    Eur J Anaesthesiol; 2015 Mar; 32(3):152-9. PubMed ID: 25046561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative leukocytosis among female patients predicts poor postoperative outcomes following endovascular aneurysm repair for intact infrarenal abdominal aortic aneurysms.
    Nejim B; Chau M; Ramirez Castello C; Aziz F; Flohr TR
    J Vasc Surg; 2021 Dec; 74(6):1843-1852.e3. PubMed ID: 34174377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery.
    Halkos ME; Lattouf OM; Puskas JD; Kilgo P; Cooper WA; Morris CD; Guyton RA; Thourani VH
    Ann Thorac Surg; 2008 Nov; 86(5):1431-7. PubMed ID: 19049726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The association between preoperative length of stay and surgical site infection after lower extremity bypass for chronic limb-threatening ischemia.
    Stewart LM; Spangler EL; Sutzko DC; Pearce BJ; McFarland GE; Passman MA; Patterson MA; Haverstock B; Unger K; Novak Z; Beck AW
    J Vasc Surg; 2021 Apr; 73(4):1340-1349.e2. PubMed ID: 32889070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for 30-day unplanned readmission following infrainguinal endovascular interventions.
    Bodewes TC; Soden PA; Ultee KH; Zettervall SL; Pothof AB; Deery SE; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 Feb; 65(2):484-494.e3. PubMed ID: 28126175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating glycemic control in patients undergoing lower extremity bypass within an enhanced recovery pathway at a single institution.
    Banks CA; Novak Z; Beck AW; Pearce BJ; Patterson MA; Passman MA; Sutzko DC; Tariq M; Morgan M; Spangler EL
    J Vasc Surg; 2023 Sep; 78(3):754-763. PubMed ID: 37116596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of open and endovascular procedures in patients with critical limb ischemia on dialysis.
    Ramanan B; Jeon-Slaughter H; Chen X; Modrall JG; Tsai S
    J Vasc Surg; 2019 Oct; 70(4):1217-1224. PubMed ID: 30922740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of diabetes mellitus on costs and length of stay in patients with peripheral arterial disease undergoing vascular surgery.
    Malone M; Lau NS; White J; Novak A; Xuan W; Iliopoulos J; Crozier J; Dickson HG
    Eur J Vasc Endovasc Surg; 2014 Oct; 48(4):447-51. PubMed ID: 25116276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
    Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
    J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of bypass and endovascular interventions for advanced femoropopliteal disease in patients with premature peripheral artery disease.
    Kim TI; Zhang Y; Cardella JA; Guzman RJ; Ochoa Chaar CI
    J Vasc Surg; 2021 Dec; 74(6):1968-1977.e3. PubMed ID: 34090986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementation of Transitional Care Planning is Associated with Reduced Readmission Rates in Patients Undergoing Lower Extremity Bypass Surgery for Peripheral Arterial Disease.
    Medina D; Zil-E-Ali A; Daoud D; Brooke J; Lee Chester-Paul K; Aziz F
    Ann Vasc Surg; 2022 Aug; 84():28-39. PubMed ID: 35271961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome?
    O'Sullivan CJ; Hynes N; Mahendran B; Andrews EJ; Avalos G; Tawfik S; Lowery A; Sultan S
    Eur J Vasc Endovasc Surg; 2006 Aug; 32(2):188-97. PubMed ID: 16580235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preexisting Conditions Determine the Occurrence of Unplanned Readmissions after Procedures for Treatment of Peripheral Arterial Disease.
    Aziz F; Lehman EB
    Ann Vasc Surg; 2018 Jul; 50():60-72. PubMed ID: 29481929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia.
    Hicks CW; Najafian A; Farber A; Menard MT; Malas MB; Black JH; Abularrage CJ
    J Vasc Surg; 2016 Dec; 64(6):1667-1674.e1. PubMed ID: 27871493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.